Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: Aids clinical trials group study A5199, the international neurological study

• Main Authors: Robertson K., Jiang H., Kumwenda J., Supparatpinyo K., Evans S., Campbell T., Price R., Tripathy S., Kumarasamy N., La Rosa A., Santos B., Silva M., Montano S., Kanyama C., Faesen S., Murphy R., Hall C., Marra C., Marcus C., Berzins B., Allen R., Housseinipour M., Amod F., Sanne I., Hakim J., Walawander A., Nair A.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84865482221&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42792
• Institution: Chiang Mai University

Background. AIDS Clinical Trials Group (ACTG) A5199 compared the neurological and neuropsychological (NP) effects of 3 antiretroviral regimens in participants infected with human immunodeficiency virus type 1 (HIV-1) in resource-limited settings.Methods.Participants from Brazil, India, Malawi, Peru,...